Strong Independent Association of TILs with OS for Patients with ERBB2-positive Early Breast Cancer By Ogkologos - February 26, 2025 774 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from updated analysis of the ShortHER study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Cancer Researchers Bring Tools, Experience to COVID-19 Studies February 12, 2021 Metastatic Colorectal Cancer May Spread Early in the Disease, Study Finds July 22, 2019 Combining Radiotherapy with SOC Plus Abiraterone Improves rPFS in Patients with... December 5, 2024 Active Monitoring Promising for Women with Low-Risk Ductal Carcinoma In Situ January 8, 2025 Load more HOT NEWS Population-based lung cancer screening can reduce mortality in people who have... Belzutifan Shows a Significant Benefit Over Everolimus in Patients with Advanced... RANO and Modified RANO Criteria Demonstrate Similar Correlations Between PFS and... EMA Recommends Extension of Therapeutic Indications for Selinexor
